Citation Impact

Citing Papers

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Telemedicine for healthcare: Capabilities, features, barriers, and applications
2021 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting
2019
Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013
2016
Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France
2017 Standout
Status and perspectives of claims data analyses in Germany—A systematic review
2016 Standout
Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial
2013
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
2018 Standout
Incidence, Mortality, and Sex Differences of Non‐Valvular Atrial Fibrillation: A Population‐Based Study
2014
GLP-1 receptor agonists: an updated review of head-to-head clinical studies
2021
WFH Guidelines for the Management of Hemophilia, 3rd edition
2020 Standout

Works of Ulf Maywald being referenced

Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus
2015
Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients
2012
Oral anticoagulation use by patients with atrial fibrillation in Germany
2012
Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis
2015
Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures
2013
Rankless by CCL
2026